Last updated: November 8, 2023
Sponsor: ZimVie
Overall Status: Active - Not Recruiting
Phase
N/A
Condition
N/ATreatment
T3 dental implant system
Clinical Study ID
NCT05062863
1804
Ages > 18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients of either sex and at least 18 years of age.
- Patients for whom a decision has already been made to use a dental implant for therestoration of existing edentulism in the mandible and/or maxilla.
- Prior extracted sites or simultaneous extraction/implant placement.
- Patients must be physically able to tolerate conventional surgical and restorativeprocedures.
- Patients who provide a signed informed consent.
- Patients who agree to be evaluated for each study visit.
Exclusion
Exclusion Criteria:
- Patients who are known to be pregnant at the screening visit or planning to becomepregnant within 6 months of study enrollment.
- Patients who have previously failed dental implants at the site intended for studyimplant placement.
- Patients with active HIV or Hepatitis infection.
Study Design
Total Participants: 140
Treatment Group(s): 1
Primary Treatment: T3 dental implant system
Phase:
Study Start date:
October 20, 2021
Estimated Completion Date:
June 30, 2025
Study Description
Connect with a study center
Dr. Daniel Engler-Hamm
München, 80333
GermanySite Not Available
University of Florida
Gainesville, Florida 32610
United StatesSite Not Available
Jersey Shore University Medical Center
Neptune, New Jersey 07753
United StatesSite Not Available
Virginia Commonwealth University
Richmond, Virginia 23298
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.